We are live on
!
Find out more
Immunic
IMUX
IMUX
63 hedge funds and large institutions have $50.7M invested in Immunic in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
37% more capital invested
Capital invested by funds: $36.9M → $50.7M (+$13.8M)
7% more funds holding
Funds holding: 59 → 63 (+4)
1.03% less ownership
Funds ownership: 5.58% → 4.55% (-1%)
25% less call options, than puts
Call options by funds: $428K | Put options by funds: $570K
Holders
63
Holders Change
+4
Holders Change %
+6.78%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
20
Reduced
12
Closed
8
Calls
$428K
Puts
$570K
Net Calls
-$142K
Net Calls Change
+$348K
Top Buyers
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$3.71M |
| 2 |
AG
Artal Group
Luxembourg
|
-$1.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.06M |
| 4 |
Morgan Stanley
New York
|
-$783K |
| 5 |
AC
AWH Capital
Dallas,
Texas
|
-$745K |
